EBCOG position statement about the use of herbal medication during pregnancy
Pregnant women often resort to herbal medication to ameliorate the disturbing symptoms associated with pregnancy in the mistaken belief…
News
EBCOG Congress – Latest Information!
We are all living through exceptional times and for some of us experiencing medical situations and organisationsal response we never…
EBCOG congress 2022 will be in Krakow
EBCOG council is taking place in Brussels. On the first day, we had two important elections. In the bid to host 2022 EBCOG congress,…
EBCOG position statement – Vaccination in pregnancy
Maternal immunization has the potential to reduce morbidity and mortality from infectious diseases worldwide. EBCOG promotes this public…
EBCOG Fellowship – application deadline extended!
EBCOG annually awards three fellowships of 3000EUR to the European Obstetrics and Gynaecology Trainees. Candidates are expected to…
EBCOG and Flo Health Inc., the developer of Flo, an AI-powered women’s health app, have signed a coo
The European Board and College of Obstetrics and Gynaecology (EBCOG) and Flo Health Inc., the developer of Flo, an AI-powered women’s…
EBCOG position statement – Public health role of sexual health andnrelationships education
Sexual and relationship education should be part of educational curriculum in early teenage years. The young people should be provided…
EBCOG Position Statement – Travelling when pregnant
Pregnant women may want to travel to go on holiday, to visit friends or family or for work related purposes. For the majority of pregnant…
Professor André Van Assche passed away on 30th July, 2018
Undiagnosed hyperglycaemia during pregnancy has now been identified as an important cause of neonatal and maternal morbidity and…
FIGO’s response to the global challenge of hyperglycemia in pregnancy
The growing burden of diabetes is becoming a major threat to women’s health. Hyperglycemia can impact her whole sexual and reproductive…